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T cell receptor (TCR) engagement in the absence of
costimulation induces the calcium-dependent upre-
gulation of a program of gene expression that leads
to the establishment of T cell anergy. Casp3 is one
of the genes activated during anergy induction.
Here we show that caspase 3 is required for the
induction of T cell unresponsiveness. Suboptimal
T cell stimulation induced caspase 3 activation,
which did not result in cell death. Furthermore, cas-
pase 3-deficient T cells showed impaired responses
to anergizing stimuli. In anergic T cells, activated cas-
pase 3 associated to the plasma membrane, where it
cleaved and inactivated proteins such as the Grb2-
related adaptor downstream of shc (GADS) and the
guanine-nucleotide exchange factor Vav1, causing
a blockade in TCR signaling. Our results identify
a role for caspase 3 in nonapoptotic T cells and
support that caspase 3-dependent proteolytic inacti-
vation of signaling proteins is essential to maintain
T cell tolerance.
INTRODUCTION
Random rearrangements of the gene segments at the T cell
receptor (TCR) locus allow recognition of foreign antigens but
also generate dangerous self-reactive T cells. Many cells carry-
ing self-reactive TCRs are eliminated during negative selection in
the thymus; however, this process has limitations and additional
mechanisms of tolerance are required in the periphery to limit au-
toimmunity. Anergy is induced in T cells by partial or suboptimal
stimulation, which results in functional inactivation of self-reac-
tive cells. Anergic T cells show profound defects in interleukin 2
(IL-2) production and proliferation (Schwartz, 2003).
Clonal anergy is induced upon engagement of the TCR in the
absence of costimulatory signals (Jenkins and Schwartz, 1987;
Quill and Schwartz, 1987). Anergizing stimuli cause a sustained
increase in intracellular free calcium, which induces the calci-
neurin-mediated dephosphorylation and nuclear translocation
of members of the nuclear factor of activated T cells (NFAT)
family of transcription factors, in the absence of full activation
of activator protein 1 (AP-1) complexes (Jain et al., 1993; Macianet al., 2001, 2002). NFAT proteins play a key role in the induction
of tolerance in T cells by driving the expression of anergy-induc-
ing genes (Macian et al., 2002). The specific expression of these
genes is required to impose a state of functional unresponsive-
ness through different mechanisms. Anergizing stimuli upregu-
late the expression of at least three E3-ubiquitin ligases: the
Casitas B-lineage lymphoma b (Cbl-b), the itchy E3 ubiquitin pro-
tein ligase homolog (Itch), and the gene related to anergy in
lymphocytes (GRAIL) (Anandasabapathy et al., 2003; Heiss-
meyer et al., 2004; Jeon et al., 2004), with a role in the downregu-
lation of TCR signaling by inactivation or degradation of signaling
molecules (Mueller, 2004). For instance, Itch and its related
protein, the neural precursor cell expressing developmentally
downregulated (Nedd) 4, have been shown to translocate to de-
tergent-insoluble membrane fractions where they induce ubiqui-
tination and degradation of phospholipase C-g and protein
kinase C-q (Heissmeyer et al., 2004).
Caspase 3 is an effector member of the caspase family that is
also expressed during anergy induction. This protease recog-
nizes proteinswith a commonDXXDmotif, cleaving after the sec-
ond aspartic residue (Rathmell and Thompson, 1999; Thornberry
and Lazebnik, 1998). Caspase 3 is expressed as a proenzyme (32
KDa) that contains a short prodomain, a large (17 KDa) subunit,
and a small (12 KDa) subunit. Activation requires proteolytic
cleavage between the subunits, where linker segment is typically
removed by upstream initiator caspases (Boatright and Salve-
sen, 2003). T andB cells fromCasp3/mice showhyperprolifer-
ative responses, which have been attributed to reduced activa-
tion-induced cell death (AICD) (Alam et al., 1999) and to
alterations of cell-cycle regulation (Woo et al., 2003), respec-
tively. Caspase 3 also regulates many nonapoptotic cellular pro-
cesses, such as cell proliferation, cell-cycle regulation, and cell
differentiation (Algeciras-Schimnich et al., 2002; Denis et al.,
1998). For instance, caspase 3 is implicated in the regulation of
the late steps of T cell activation (Alam et al., 1999; Miossec
et al., 1997), IL-16 processing (Zhang et al., 1998), dendritic
cell maturation (Santambrogio et al., 2005), and erythrocyte
(Kolbus et al., 2002) and monocyte (Sordet et al., 2002)
differentiation.
In this study we have characterized the activation of caspase
3 in anergic T cells and determined its role in the inhibition of
TCR signaling. We show that anergizing stimuli led to increased
caspase 3 activation in the absence of apoptotic hallmarks.
Activated caspase 3 associated then to the plasma membrane,
where it was responsible for the cleavage of GADS and Vav1
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caspase 3 in nonapoptotic T cells and reveal that caspase 3-de-
pendent proteolytic inactivation of signaling proteins is essential
to block TCR signaling in anergic cells and, therefore, tomaintain
T cell tolerance.
RESULTS
Caspase 3 Is Activated during Anergy
Induction in T Cells
We had previously shown that the expression of caspase 3
mRNA was induced in T cells that became unresponsive after
being treated with the calcium ionophore ionomycin (Macian
et al., 2002). We observed similar results when Th1 cells were
anergized with anti-CD3. A clear upregulation of caspase 3
mRNA expression was detected in cells stimulated with anti-
CD3 when compared to resting cells or cells stimulated with
anti-CD3 and anti-CD28 (Figure 1A). Interestingly, caspase 3
mRNA was still clearly upregulated even when cells received
a costimulatory signal in the form of CD28 antibodies after
T cells had already been exposed for 2 hr to anti-CD3, which
suggests that once the transcriptional complexes that induce
caspase 3 transcription are formed, engagement of CD28 might
not be sufficient to disrupt them (Figure 1B). Similar results were
obtained when DO11.10 Th1 cells were stimulated with CHO
cells expressing MHC class II IAd molecules (CHO-IAd) loaded
with the ovalbumin Ova323-339 peptide (OVA), and compared
with resting cells or cells activated via CHO-IAd cells that also
expressed B7.2 (CHO-IAd-B7) (Figure 1C). Stimulated cells
also showed some degree of caspase 3 mRNA upregulation, al-
though much smaller than in anergic cells. In order to assess
whether caspase 3 proteolytic activity played any role in the
induction of T cell anergy, we determined whether increased
gene expression correlated with activation. Anergy was induced
by coculturing DO11.10 Th1 cells with CHO-IAd cells loaded with
OVA peptide. As controls, we cocultured Th1 cells with unloaded
CHO-IAd cells or with OVA-loaded CHO-IAd-B7 cells. T cells
were then recovered, rested for 3 days, and restimulated with
anti-CD3 and anti-CD28. Induction of anergy was confirmed by
decreased proliferation and IL-2 production in Th1 cells that
had been previously stimulated with OVA-loaded CHO-IAd,
compared to control cells (Figures 1D and 1E). We then deter-
mined caspase 3 processing by immunoblot, detected by the
presence of a 17 KDa band. Proteolytic activation of caspase 3
was observed only in T cells that had received an anergic stimu-
lus, but not in resting or fully stimulated T cells (Figure 1F). To bet-
ter characterize the activation of caspase 3, we determined the
kinetics of processing during the induction of T cell anergy.
Cleavage was evident 6 hr after anergizing stimulation and in-
creased with time (Figure 1G, top). As we had previously shown
for caspase 3 expression, activation also seemed to be depen-
dent on calcium signaling, because proteolytic processing was
observed with similar kinetics in response to ionomycin
(Figure 1G, bottom). In an attempt to identify the mechanism re-
sponsible for the activation of caspase 3 in anergic T cells, we
determined whether caspase 8 and caspase 9 were also
activated in response to anergizing stimuli. We could not detect
activation of these proteases in anergic cells (see Figure S1A
available online). Similarly, the use of biotin-ZVAD-fmk to pull
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caspase 3, but not caspase 8 or caspase 9, was activated in
response to an anergizing stimulus (Figure S1B). Recent reports
had indicated that calpain, a calcium-regulated protease, could
be involved in the activating cleavage of caspase 3 (McCollum
et al., 2002; McGinnis et al., 1999). In order to investigate this
possibility in anergic T cells, we anergized Th1 cells with ionomy-
cin in the presence of different concentrations of the calpain
inhibitor calpeptin. Calcium-induced caspase 3 cleavage was
greatly reduced in the presence of calpeptin, suggesting that
calpain may be responsible, at least in part, for the activation
of caspase 3 in anergic T cells (Figure 1H). Supporting the impor-
tant role of calpain in the activation of caspase 3 in anergic cells,
ionomycin-induced hyporesponsiveness in Th1 cells was com-
promised by the inhibition of calpain with calpeptin (Figure S2).
Taken together, these results indicated that caspase 3 was acti-
vated in T cells in response to calcium signaling induced by aner-
gizing stimuli.
Caspase 3 Activation in Anergic T Cells
Does Not Induce Apoptosis
Given the key role that caspase 3 plays during apoptosis, we ex-
amined whether its increased activation in anergic T cells could
be a consequence of the induction of apoptosis. We analyzed
changes in the distribution of membrane phosphatidyl-serine,
staining with phycoeritrin (PE)-conjugated Annexin V, and DNA
fragmentation, by using a TUNEL assay. Th1 cells were rendered
unresponsive by ionomycin treatment and compared with un-
treated controls, whereas cells treated with staurosporine were
used as apoptotic controls. Anergic cells showed a clear
increase in the levels of active caspase 3, but no differences in
Annexin V or TUNEL staining were observed when compared
to control cells (Figures 2A and 2B). Similar results were obtained
when T cells were anergized in the presence of CHO-IAd and
OVA and compared with T cells cultured with unloaded CHO-IAd
cells (Figure 2C). To understand the differences in caspase
3 activation between anergic and apoptotic T cells, wemeasured
the magnitude of caspase 3 activity in anergic cells and in
apoptotic T cells by using a caspase 3 activity assay (Figure 2D).
Results showed that, as suggested by our FACS analysis, the in-
crease in caspase 3 activity in anergic cells wasmuch lower than
in apoptotic cells. We could not detect, though, differences in the
expression of several negative regulators of caspase activity that
might have accounted for the limited caspase 3 activation in
anergic cells (Figure S3). We also compared the cleavage of
two proapoptotic substrates processed by caspase 3 in apopto-
tic cells. Although the poly (ADP-ribose) polymerase (PARP) 1
and the inhibitor of caspase-3-activated DNase (ICAD) were
clearly cleaved in apoptotic T cells, no processing of these sub-
strates could be detected in anergic cells (Figure 2E).
Thus, activation of caspase 3 in anergic T cells did not result in
the proteolytic cleavage of typical proapoptotic caspase
substrates and consequently did not cause cell death.
Inhibition of Caspase Activity Compromises
Anergy Induction
To determine the role of caspase 3 in the establishment of T cell
anergy, we studied the effect of inhibiting its activation during the
induction of anergy. For this purpose, we added the caspase
Immunity
Caspase 3 Inhibits T Cell Receptor SignalingFigure 1. Anergic T Cells Activate Caspase 3
(A and B) Th1 cells were stimulated with anti-CD3 and/or anti-CD28 for 6 hr and caspase 3 mRNA measured by (A) RNase protection assay or (B) qPCR. Where
indicated, cells treated with anti-CD3 received anti-CD28 with a 2 hr delay (delaCD28). Results (mean + SEM) are n-fold induction of mRNA expression relative to
the control resting cells from at least four experiments.
(C) DO11.10 Th1 cells were cocultured for 6 hr with CHO-IAd cells loaded or not with OVA or fully stimulated with OVA-loaded CHO-IAd-B7 cells. Amounts of
Casp3 mRNA were analyzed by qPCR. Results are mean + SEM of three experiments.
(D and E) DO11.10 Th1 cells were cocultured for 12 hr with CHO-IAd cells, loaded or not with OVA or with OVA-loaded CHO-IAd-B7 cells. After a 3 day resting
period, cells were stimulated with anti-CD3+anti-CD28 and (D) BrdU incorporation and (E) IL-2 production measured. Bars showmean + SEM from at least three
experiments.
(F) Th1 cells were treated as described in (D) and caspase 3 processing detected by immunoblot.
(G) Th1 cells were stimulatedwithOVA-loadedCHO-IAd (top) or ionomycin (bottom). Processing of caspase 3wasmeasured at different timepointswith a specific
antibody for its active form. Actin was detected as a loading control.
(H) Th1 cells were treated with ionomycin for 6 hr in the presence of calpeptin or control vehicle (DMSO). Caspase 3 activation was detected by immunoblot. Actin
was detected as a loading control. Densitometric quantifications of two independent experiments are shown (mean + SEM).inhibitor Z-VAD to T cells 30 min before being anergized with
OVA-loaded CHO-IAd cells. Inhibition of caspase 3 activation
was confirmed in a fraction of the treated cells (Figure 3A). After
the anergizing treatment, the caspase inhibitor was washed outand cells were rested for 3 days before being restimulated with
anti-CD3 and anti-CD28. We observed a marked impairment in
the induction of anergy in Th1 cells anergized in the presence
of Z-VAD. Whereas anergic cells show very poor proliferative
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Caspase 3 Inhibits T Cell Receptor SignalingFigure 2. Activation of Caspase 3 Does Not Induce Apoptosis in Anergic T Cells
(A) DO11.10 Th1 cells treated with ionomycin or left resting for 12 hr. T cells were then recovered, washed, stained with an antibody against the active form of
caspase 3 (left) or with Annexin V-PE (center), and analyzed by FACS. T cells treatedwith staurosporine (1 mM, 4 hr) were used as positive control for Annexin V-PE
staining (right).
(B) Apoptosis was also detected by TUNEL assay in Th1 cells treated with 1 mM ionomycin for 12 hr or with staurosporine for 4 hr (right). The same cells were also
stained for active caspase 3 (left).
(C) Similar analyses were performed in T cells cultured for 12 hr with CHO-IAd cells loaded or not with OVA.
(D) Caspase 3 activity was measured with a fluorogenic caspase-3 substrate in cell lysates from Th1 cells left resting, anergized with ionomycin for 12 hr, or
treated with 1 mM staurosporine for 4 hr.
(E) Th1 cells were left resting, incubated with 1 mM ionomycin for 12 hr, or treated with 1 mMstaurosporine for 4 hr. Total cell lysates were analyzed by immunoblot
with antibodies that recognized the proapoptotic caspase 3 substrates PARP1 and ICAD.responses to stimulation, cells anergized in the presence of
Z-VAD proliferated upon restimulation almost aswell as untreated
or previously stimulated control T cells (Figure 3B). To confirm
196 Immunity 29, 193–204, August 15, 2008 ª2008 Elsevier Inc.these results, cells were also anergized with irradiated spleno-
cytes loaded with OVA and a cytotoxic T-lymphocyte antigen 4
(CTLA-4)-Ig fusion protein to block B7 molecules. With this
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Caspase 3 Inhibits T Cell Receptor SignalingFigure 3. Inhibition of Caspase Activity Compromises Anergy Induction in T Cells
(A and B) DO11.10 Th1 cells were anergized by coculture for 12 hr with OVA-loadedCHO-IAd cells. Z-VAD or control vehicle (DMSO)were addedwhere indicated.
Th1 cells cocultured with CHO-IAd cells or with OVA-loaded CHO-IAd-B7 cells were used as controls.
(A) Z-VAD inhibition of caspase 3 activation was determined by intracellular staining for active caspase 3 or immunoblot.
(B) Degree of anergy after treatments was determined bymeasuring BrdU incorporation after anti-CD3+anti-CD28 stimulation. Values are mean + SEM of at least
three different experiments.
(C and D) DO11.10 Th1 cells were anergized with irradiated splenocytes preincubated with OVA and CTLA-4-Ig. Z-VAD was added where indicated. After 12 hr,
T cells were recovered, washed, and rested for 3 days before restimulation with anti-CD3+anti-CD28. IL-2 production was measured by (C) RNase protection
assay or (D) ELISA. Untreated control cells were also analyzed. S, stimulated; R, resting. Values are mean + SEM of at least three different experiments.protocol, cells anergized in the presence of Z-VAD produced,
after restimulation, several times more IL-2 than cells anergized
without Z-VAD (Figures 3C and 3D). Our data suggested, there-
fore, that caspase activity was required for the induction of
anergy in T cells in response to partial stimulation.
Caspase 3 Is Necessary to Induce Anergy in T Cells
We next addressed whether specifically caspase 3 activity was
required to induce T cell hyporesponsiveness. Th1 cells were
transfected with a plasmid expressing a shRNA specific for
caspase 3 mRNA, which led to a marked reduction of caspase 3expression (80%) and almost no detectable caspase 3 activa-
tion after anergy induction (Figure 4A and data not shown). Inhi-
bition of IL-2 expression after anergizing treatment with ionomy-
cin was significantly impaired in cells expressing a specific
shRNA for Casp3 compared to control cells (IL-2 expression re-
duced to 56%and 16%, respectively, after anergizing treatment;
p < 0.01) (Figure 4B). We confirmed these results by using Th1
cells from Casp3/ mice. Cells were anergized with ionomycin
for 12 hr and IL-2 production was measured after restimulation
with anti-CD3 and anti-CD28. As previously seen in cells in which
Casp3 expression had been inhibited with a shRNA, Casp3/
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than were Casp3+/+ T cells (IL-2 expression reduced to 67%
and 13%, respectively, after treatment with ionomycin; p <
0.05) (Figure 4C). Under these conditions, we could not detect
differences in the degree of apoptosis induced in anergic
wild-type or Casp3/ T cells after stimulation with anti-CD3
and anti-CD28 (Figure S4). These data demonstrated, thus,
that calcium-induced caspase 3 activity was necessary for the
establishment of T cell unresponsiveness.
Caspase 3 Cleaves GADS and Vav1 in Anergic T Cells
Several TCR signaling components have been reported as cas-
pase substrates during apoptosis or after CD95-induced inhibi-
tion of antigen receptor signaling, including the Grb2-related
adaptor downstream of shc (GADS) (Berry et al., 2001), the gua-
nine-nucleotide exchange factor Vav1 (Hofmann et al., 2000), the
TCRz chain (Gastman et al., 1999), and PLCg (Bae et al., 2000).
By analyzing total cell extracts from anergic T cells, we were able
to detect degradation of GADS (Figure 5A). No detectable
cleavage was found in other substrates (data not shown). This
cleavage was caspase 3 dependent as indicated by the fact
Figure 4. Blocking Caspase 3 Expression Interferes with the Induc-
tion of Anergy
(A) Th1 cells were transfected with a GFP-expressing vector only or together
with the pC3-shRNA, which expresses a specific caspase 3 shRNA or control
pSup vector. Cells were then sorted for GFP expression and treated with 1 mM
ionomycin for 12 hr, and caspase 3 and actin were detected by immunoblot.
(B) Untreated and ionomycin-treated control T cells and T cells transfected
with a plasmid expressing a Casp3 shRNA were stimulated with anti-
CD3+anti-CD28 and IL-2 production measured by ELISA. Bars show percent-
age of IL-2 expression relative to control stimulated cells and are mean + SEM
of three experiments. **p < 0.01.
(C) CD4+ T cells were isolated from Casp3/ mice and wild-type littermates.
Absence of caspase 3 expression in Casp3/ cells was confirmed by immu-
noblot. T cells were differentiated under Th1 skewing conditions and then left
resting or treated with 1 mM ionomycin for 12 hr. Cells were then washed and
left resting for 6–8 hr before restimulation with anti-CD3+anti-CD28. Inhibition
of IL-2 production in Casp3/ T cells was compared with that of wild-type
anergized T cells. Bars show percentage of IL-2 expression in anergic cells
compared with control stimulated cells and are mean + SEM of six mice.
*p < 0.05.
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sults were obtained when T cells from DO11.10 mice were toler-
ized in vivo by oral feeding with ovalbumin (Figure 5C, left). Orally
tolerized CD4+ T cells activated caspase 3 and showed cleavage
of GADS and Vav1 (Figure 5C, right).
Amounts of GADS and Vav1 cleavage detected were moder-
ate, suggesting that only a reduced fraction of the total cell con-
tent of those proteins was being processed by caspase 3. One
possible explanation could be that only the fraction of GADS
and Vav1 recruited to the TCR-associated signaling complex
could become target of caspase 3 activity. To test this hypothe-
sis, we first analyzed the subcellular localization of active
caspase 3 in anergic T cells. The active form of caspase 3 was
detected only in the pellet but not in the soluble fraction of
a S100 lysate, suggesting membrane localization (Figure 6A,
left). Further subfractionation assays showed that active cas-
pase 3 appeared clearly associated with the plasma membrane
fraction, but not with those containing other organelles or with
nuclear fractions (Figure 6A, right). Purity of the fractions was as-
sessed with antibodies against connexin43, GM130, and Bcl-2
(data not shown). This specific subcellular localization would
provide a way to restrict caspase 3 activity to signaling mole-
cules recruited to the membrane during T cell activation. In order
to test this hypothesis, we analyzed the cleavage of GADS and
Vav1 in anergic cells after restimulation. Th1 cells derived from
Casp3+/+ or Casp3/ mice were treated with ionomycin in the
presence or absence of the caspase inhibitor Z-VAD for 12 hr
to induce anergy. Cells were thenwashed and left resting for sev-
eral hours before restimulation. No differences in the levels of
Annexin V staining could be detected between stimulated aner-
gic and nonanergic cells, ruling out the possibility that increased
caspase 3-mediated processing might result from increased
apoptosis in anergic T cells (Figure 6B). As hypothesized, stimu-
lation of T cells led to increased GADS and Vav1 cleavage in
anergic cells (Figures 6C and 6D). A very low degree of process-
ing could also be observed in nonanergic cells, which could re-
sult from a fraction of cells that might have been only subopti-
mally stimulated in our assay, or from some small amount of
apoptosis induced during stimulation. As shown before, this
cleavage was caspase 3 dependent, as indicated by the fact
that it was blocked by a caspase inhibitor (Figure 6C) and was
absent in Casp3/ T cells (Figure 6D).
If the blockade of TCR signaling was a consequence of the
caspase-dependent cleavage of Vav1 and GADS, we should
be able to reverse this effect by using caspase-resistant forms
of these proteins. Th1 cells were transfected with plasmids ex-
pressing either wild-type or caspase-resistant forms of GADS
and Vav1 bearing mutations in the caspase-recognition site
that rendered them resistant to caspase 3-mediated cleavage
(Berry et al., 2001; Hofmann et al., 2000). Ionomycin-induced
hyporesponsiveness, measured as decreased IL-2 production
upon restimulation, was similar in control cells and in cells trans-
fected with wild-type proteins, but was significantly reduced in
cells expressing the caspase-resistant GADS or Vav1. This effect
was even more pronounced when both proteins were coex-
pressed together (Figure 6E).
To exclude the possibility that the cleaved fragments might
have an effect on T cell activation, we transduced primary
T cells with retrovirus expressing the different fragments that
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GADS. Cells expressing either of the two different fragments or
both fragments at the same time were then stimulated with anti-
CD3 and anti-CD28. The expression of those fragments did not
cause any effect on IL-2 production, suggesting that the loss of
function seen in anergic T cells was likely a consequence of the
cleavageof theseproteins and not of alterations in signaling path-
ways caused by the cleaved fragments (Figure 6F).
Collectively, these results indicated that active caspase 3 was
recruited to the plasmamembrane in anergic cells where it could
inhibit T cell activation by cleaving and inactivating GADS and
Vav1.
Caspase 3 Cleavage of Vav1 Prevents Its Recruitment
to the Plasma Membrane
Vav1 is recruited to themembrane upon engagement of the TCR.
To determine whether cleavage by caspase 3 could prevent this
recruitment, we analyzed Vav1 subcellular localization after TCR
engagement in control and anergic T cells. As expected, in
resting cells Vav1 resided mostly in the cytosol, but was readily
recruited to the membrane upon stimulation. This effect was
blocked in anergic cells, which showed markedly reduced
Vav1 recruitment to the plasma membrane after stimulation
with anti-CD3 and anti-CD28 (Figure 7A). To corroborate the
effect that cleavage of Vav1 had on its subcellular localization,
Figure 5. Caspase 3 Cleaves GADS and Vav1 in
Anergic T Cells
(A) DO11.10 Th1 cells were cocultured for 12 hr with
CHO-IAd cells loaded or not with OVA, or with OVA-loaded
CHO-IAd-B7 cells. T cells were then recovered and cas-
pase 3 and GADS processing determined.
(B) Casp3/ and wild-type littermate Th1 cells were
treated for 12 hr with ionomycin and processing of
caspase 3 and GADS detected by immunoblot.
(C) DO11.10 mice were orally tolerized with ovalbumin.
Seven days later, CD4+ T cells were isolated and stimu-
lated with anti-CD3+anti-CD28. IL-2 production was mea-
sured by ELISA. Proteolytic cleavage of caspase 3, GADS,
and Vav1 was determined by immunoblot. Results are
from two different mice from each group (mean + SEM).
we analyzed membrane recruitment in aner-
gized cells previously transduced with retrovi-
ruses that expressed either wild-type or
a caspase 3-resistant Vav1. In control cells
transducedwith a virus expressing GFP, recruit-
ment of Vav1 to the plasmamembrane upon ac-
tivation was greatly reduced in anergic T cells.
Overexpression of a wild-type Vav1 resulted in
a small increase in membrane recruitment that
was not significant and likely due to the overex-
pression of this protein. However, the expres-
sion of the caspase 3-resistant Vav1 completely
restored recruitment of Vav1 to themembrane in
anergic cells to a degree similar to that found in
nonanergic control T cells (Figure 7B). These
data further supported that caspase 3 localiza-
tion to the plasma membrane in anergic T cells
resulted in the inhibition TCR signaling by allowing this protease
to target and cleave Vav1 and prevent its proper activation-
induced recruitment to the membrane.
DISCUSSION
It is becoming increasingly evident that caspases are versatile
proteases that control many cellular functions other than apopto-
sis. Here we show that caspase 3 negatively regulates TCR
signaling in anergic T cells. Anergy is induced in T cells by subop-
timal stimulation that causes sustained calcium signaling and
the consequent activation of the calcineurin-NFAT axis (Bandyo-
padhyay et al., 2007; Borde et al., 2006; Heissmeyer et al., 2005).
We have shown that under these conditions, the expression of
a specific set of genes is upregulated (Macian et al., 2002), which
encode proteins responsible for the inhibition of T cell activation
(Anandasabapathy et al., 2003; Heissmeyer et al., 2004; Jeon
et al., 2004; Olenchock et al., 2006; Su et al., 2006; Zha et al.,
2006). Caspase 3 is also expressed in anergic T cells in a calcium/
NFAT-dependent manner (Macian et al., 2002; Kaji et al., 2003).
Our results show now that caspase 3 is activated in nonapoptotic
anergic T cells and that the activity of this protease is necessary
to maintain anergic T cells hyporesponsive.
Originally described as a crucial regulator of apoptosis, cas-
pase 3 has also been shown to regulate other processes
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Caspase 3 Inhibits T Cell Receptor SignalingFigure 6. Active Caspase 3 Associates to the Plasma Membrane in Anergic T Cells Where It Cleaves GADS and Vav1 after TCR Stimulation
(A) S100 fractions were prepared from resting Th1 cells or cells treated with 1 mM ionomycin for 12 hr (left). Lysates from those cells were also fractionated by
differential centrifugation in sucrose gradients into fractions containing the plasmamembrane (P1), mitochondria, lysosomes, endosomes, and peroxisomes (P2)
and the Golgi and ER (P3) (right). The presence of active caspase 3 in all fractions was detected by immunoblot.
(B and C) Th1 cells from Casp3/ or wild-type mice were treated with 1 mM ionomycin for 12 hr, washed, and rested for 4 hr before stimulation with anti-
CD3+anti-CD28 for 6 hr. Annexin V staining was detected by FACS in stimulated cells (B) and proteolytic processing of GADS and Vav1 determined in lysates
from these cells (C).
(D) Th1 cells were left untreated or treated with 1 mM ionomycin for 16 hr, washed, and left resting for 4 hr before restimulation, in the presence or absence of
Z-VAD. After 6 hr, cells were collected and proteolytic cleavage of GADS and Vav1 detected by immunoblot.
(E) Th1 cells from C57BL6/J mice were transfected with plasmids expressing wild-type or caspase-resistant (GADSr and Vav1r) murine GADS and/or Vav1.
Amounts of DNA used were adjusted to obtain similar levels of expression of all proteins. Control cells were transfected with pGFP. 36 hr after transfection, cells
were rested or treated with ionomycin 1 mM for 12 hr. IL-2 was measured by ELISA after stimulation with anti-CD3+anti-CD28. Left panel shows normalized
(to control untreated cells) IL-2 values, whereas right panel shows percentage of IL-2 expression in anergic cells compared with control cells in each experimental
condition. Bars are mean + SEM of four experiments. *p < 0.05.
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Prevents Activation-Dependent Recruit-
ment of Vav1 to the Membrane in Anergic
T Cells
(A) Vav1 membrane recruitment was determined
by immunoblot of pellet (mem) and supernatant
(cyt) S100 fractions of control and anergic Th1
cells stimulated with anti-CD3+anti-CD28. Detec-
tion of flotillin1 was used as a membrane marker.
(B) Th1 cells, transduced with virus expressing
wild-type or caspase-resistant (Vav1r) Vav1,
were sorted, and the translocation of Vav1 to the
membrane in control and anergized cells was
determined after stimulation with anti-CD3+
anti-CD28. Densitometric quantification of six
experiments (mean + SEM) is shown. **p < 0.01,
*p < 0.05.including skeletal muscle differentiation and the maturation of
erythroid precursors, monocytes, and dendritic cells (De Maria
et al., 1999; Fernando et al., 2002; Santambrogio et al., 2005;
Sordet et al., 2002; Wong et al., 2004). In B cells, caspase 3 reg-
ulates entry into the cell cycle by cleaving p21 and preventing the
formation of active cyclin/CDK complexes (Woo et al., 2003). In
T cells, caspase 8 is activated upon stimulation and controls
T cell proliferation (Alam et al., 1999; Kennedy et al., 1999).
Blocking caspase activity during T cell stimulation leads to de-
creased activation-induced proliferation and cytokine produc-
tion, which is also evident in caspase 8-deficient T cells (Alam
et al., 1999; Falk et al., 2004; Kennedy et al., 1999; Salmena
and Hakem, 2005; Salmena et al., 2003). The mechanisms re-
sponsible for this effect may reside in the ability of active
caspase 8 to induce NF-kB activation and to regulate cell cycle
in T cells (Falk et al., 2004; Su et al., 2005). Here we report that
another member of the caspase family of proteases, caspase
3, has a different role in T cell physiology and negatively regu-
lates TCR signaling in anergic T cells. Although we cannot rule
out that other mechanisms may also contribute to the activation
of caspase 3 in response to tolerogenic stimuli, our results indi-
cate that calcium signaling induces the calpain-mediated activa-
tion of this protease in anergic T cells. Caspase 3 activation has
also been reported in fully stimulated T cells, but with delayed
kinetics compared to its activation in anergic cells (Alam et al.,
1999; Misra et al., 2005). It is possible, therefore, that caspase
3 may contribute to terminate T cell activation through a mecha-
nism similar to the one that operates in anergic T cells.
Ubiquitin ligases, such as Itch and Cbl-b, have been impli-
cated in downregulating TCR signaling by targeting components
of the TCR signalosome to the endocytic pathway, leading to
their functional inactivation or degradation (Heissmeyer et al.,
2004). We propose that caspase 3-mediated cleavage of pro-
teins involved in TCR signal transduction, such as GADS and
Vav1, is also responsible for maintaining a status of hyporespon-siveness in anergic T cells. GADS is an adaptor protein that inter-
acts with the Src homology 2-domain-containing leukocyte
phosphoprotein of 76 KDa (SLP-76) and the linker for activation
of T cells (LAT) (Boerth et al., 2000; Yankee et al., 2004). GADS-
deficient T cells have profound defects in TCR signaling that
severely affect thymocyte development (Yankee et al., 2004).
Induction of apoptosis or CD95 engagement leads to the cas-
pase-dependent cleavage of GADS, which blocks productive
TCR signaling (Berry et al., 2001; Yankee et al., 2001). Vav1, a nu-
cleotide exchange factor for the RhoA, Rac1, and cdc42
GTPases (Fujikawa et al., 2003; Tybulewicz et al., 2003), is also
cleaved by caspase 3 in apoptotic T cells (Hofmann et al.,
2000). The resulting fragment fails to induce p38 activation and
cannot support transcription from NFAT, AP-1, or NF-kB re-
porter plasmids (Hofmann et al., 2000). We report here that
cleavage of these two proteins occurs also in anergic T cells.
Whereas in apoptotic cells inhibition of these signaling pathways
may prevent aberrant cytokine synthesis in a cell destined to
die, in anergic T cells this same mechanism would engage to
block T cell activation. We have confirmed that the cleavage of
GADS and Vav1 in anergic T cells is mediated by caspase 3.
Blocking caspase 3 expression with siRNA or using T cells
from caspase 3-deficient mice leads to defective anergy induc-
tion, which correlates with lack of GADS and Vav1 cleavage.
Furthermore, cells that express caspase-resistant forms of these
proteins are also resistant to anergy induction. Nevertheless,
some degree of hyporesponsiveness is still induced in these
cells, which might be due to the activation of other mechanisms
that also dampen TCR signaling in anergic T cells. Although the
results from the experiments performed with caspase-resistant
Vav1 andGADS strongly suggest a critical role for these two pro-
teins in controlling TCR signaling in anergic T cells, we cannot
rule out that other targets of caspase 3 exist in anergic T cells
and that their proteolytic processing also contributes to keep
anergic cells hyporesponsive.(F) Th1 cells were transduced with retrovirus expressing the N-terminal (Vav11-174, GADS1-223) and/or the C-terminal (Vav1172-845, GADS226-322) fragments of Vav1
and GADS. Expression of these peptides was verified by immunoblot in infected NIH 3T3 cells. IL-2 production was measured in sorted T cells after stimulation
with anti-CD3+anti-CD28. Bars are mean + SEM of at least two experiments.
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Caspase 3 Inhibits T Cell Receptor SignalingThe role of caspase 3 as a tolerance-inducing factor does not
seem to be restricted to the induction of clonal anergy in Th1
cells, because we can also detect caspase 3 activation and
cleavage of GADS and Vav1 in T cells from orally tolerized
mice. These findings support that activation of the calcium-
NFAT-dependent expression of caspase 3, and likely several
other genes, may constitute a basic mechanism for the induction
of T cell tolerance.
Substrate specificity may underlie the different roles of cas-
pase 3 in different tissues and physiological conditions and ex-
plain why its activation does not cause apoptosis in anergic
T cells. It is still not clear how this specificity might be achieved.
We could not detect differences in the expression of several
negative regulators of caspase activation; however, caspase 3
activity in anergic cells was much lower than that detected in ap-
optotic cells. More importantly, active caspase 3 seemed to be
confined to the plasma membrane, where accessibility to sub-
strates would be restricted. Supporting this idea, we could not
detect significant changes in the levels of total Vav1 in anergic
T cells; however, the presence of this protein in the plasmamem-
brane was drastically reduced in anergic cells, which could be
restored by expressing a caspase-resistant form of Vav1. Hence,
both quantitative and qualitative differences in caspase 3 activity
between anergic and apoptotic T cells may explain the different
outcomes of the activation of this protease.
Maintenance of T cell tolerance may represent just a part of
a global role of caspases as immunomodulators. Apart from its
involvement in AICD and anergy, caspase 3 has also been shown
to negatively regulate B cell progression into the cell cycle (Woo
et al., 2003). Furthermore, basal caspase 3 activity is required to
maintain dendritic cells in an immature state, and its inhibition by
activating stimuli induces dendritic cell maturation and produc-
tive presentation of antigens (Santambrogio et al., 2005; Wong
et al., 2004).
Caspase 3 plays, thus, a crucial role in the establishment and
maintenance of T cell tolerance. Calcium signals engaged in re-
sponse to tolerogenic stimuli are responsible for the activation of
caspase 3, which inhibits T cell activation by inactivating key
proteins involved in transducing signals from the TCR.
EXPERIMENTAL PROCEDURES
Mice
Mice were maintained in pathogen-free conditions. All animal work was per-
formed according to the guidelines set by the Institutional Animal Care Com-
mittee of the Albert Einstein College of Medicine. 4- to 6-week-old C57BL6/
J, BALB/c, and DO11.10 mice were purchased from Jackson Laboratories.
Casp3/ mice (Woo et al., 2003) were kindly provided by T.W. Mak.
Cell Culture
Primary CD4+ T cells were isolated from lymph nodes and spleens via mag-
netic beads (Invitrogen), stimulated with 0.5 mg/ml plate-bound anti-CD3 and
0.5 mg/ml anti-CD28 (BD), and differentiated for 7 days with 10 ng/ml IL-12
(Cell Science), 10 mg/ml anti-IL-4, and 10 U/ml of recombinant human IL-2.
Cells were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal calf serum, 2 mM L-glutamine, nonessential amino acids, es-
sential vitamins (Cambrex), and 50 mM 2-mercaptoethanol. Chinese hamster
ovary (CHO) cells expressing IAd with or without B7.2 were kindly provided
by S. Bhatia.
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Four different systems were used to induce T cell tolerance. (1) Mitomycin C
(Sigma)-pretreated CHO-IAd cells loaded with 10 mMOVA peptide were cocul-
tured with DO11.10-derived Th1 cells for 12 hr. Th1 cells were recovered and
rested for 3 days before being analyzed. (2) Th1 cells were treated with 1 mM
ionomycin (EMD) for 12 hr, washed, and rested for 4 hr before being restimu-
lated. (3) DO11.10 Th1 cells were cultured for 12 hr with irradiated BALB/c
mice splenocytes preincubated with 10 mMOVA and 10 mg/ml CTLA-4-Ig (Chi-
merigen). Th1 cells were recovered, washed, and rested for 3 days before be-
ing analyzed. In all procedures, the caspase inhibitor Z-VAD (EMD) was added
at a final concentration of 100 mMwhere indicated during anergy induction and
then washed out. (4) Oral tolerance was induced by the administration of
a single intragastric dose of 25 mg of ovalbumin (Sigma) to DO11.10 mice.
On day 7, CD4+ T cells were isolated and analyzed.
ELISA
2.5 or 5 3 104 Th1 cells were stimulated in 96-well plates. Supernatants were
collected 24 hr after stimulation and IL-2 levels were measured in a sandwich
ELISA (BD).
Proliferation Assay
25 3 103 Th1 cells were stimulated in 96-well plates. 60 hr later, 5-Bromo-20-
deoxy-uridine (BrdU) was added for 12 hr. Incorporation of BrdU was mea-
sured by ELISA according to manufacturer’s instructions (Roche).
Immunoblotting
Whole-cell extracts were prepared by boiling cell pellets directly in SDS to pre-
vent proteolysis during cell lysis. Antibodies against caspase 3 and 9 and
cleaved caspase 3 (Cell Signaling), GADS (Upstate Biotech), Vav1 (Santa
Cruz Biotech), FLIP (EMD), and Caspase 8, XIAP, Flotillin1, Connexin-43,
GM130, and Bcl-2 (BD) were used. Where indicated, the calpain inhibitor cal-
peptin (EMD) or the caspase inhibitor Z-VADwere added to cells 30min before
adding 1 mM ionomycin for 6 to 12 hr. Densitometric quantification of the
immunoblotted membranes and stained gels was done with ImageJ (National
Institutes of Health, http://rsb.info.nih.gov/ij).
Detection of Active Caspases
Total cell extracts were prepared by lysing 53 106 cells in 1 ml of RIPA buffer
with a cocktail of protease inhibitor (Roche). 100 mM of biotin-VAD-fmk (EMD)
were added for 4 hr at 4C, followed by 50 ml of streptavidin agarose beads
(Invitrogen) and incubated for 4 hr at 4C. Agarose beads were washed three
times with RIPA buffer and boiled directly in SDS.
Apoptosis Detection
Apoptosis was determined with Annexin V-PE apoptosis detection kit (BD) or
by TUNEL assay with the In situ Cell Death Detection kit (Roche). Stained cells
were analyzed on a FACSCAN (Beckton-Dickinson).
Intracellular Staining
To detect caspase 3 activation, T cells were fixed in 4% paraformaldehyde,
permeabilized in PBS/1% BSA/0.5% saponin, and incubated with an antibody
against the active fragment of caspase-3. A secondary FITC or Cy3-conju-
gated antibody was used. Cells were analyzed on a FACSCAN.
Caspase 3 Activity
T cells were plated in 96-well pates at 53 104 cells/well. Fluorogenic caspase
3 substrate IX (EMD) was added at a final concentration of 50 mM. Fluores-
cence was measured with a plate reader fluorimeter (BMG) every 5 min for
1 hr at 37C.
RNase Protection Assay
Total RNA was obtained from T cells with Trizol Reagent (Invitrogen) and ana-
lyzed with the RiboQuant multiprobe RNase protection kit with the mCK-1b or
the mAPO-1 probes (BD).
Quantitative RT-PCR
Total RNA was prepared from T cells with Trizol Reagent and used to synthe-
sized cDNA via a Superscript kit (Invitrogen). qPCR was performed with
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Caspase 3 Inhibits T Cell Receptor Signalinga SYBR green master mix (Stratagene) as described before (Macian et al.,
2002) with specific primers to amplify a fragment from the caspase 3 cDNA
(50-ACGCGCACAAGCTAGAATTT, 50-CTTTGCGTGGAAAGTGGAGT).
Plasmids and T Cell Transfection
Plasmids expressing the wild-type murine GADS and a caspase resistant mu-
tant form (D235A) were kindly provided by C.J. McGlade (Berry et al., 2001; Liu
and McGlade, 1998). A wild-type Vav-1-expressing construct was kindly pro-
vided by X.R. Bustelo. Vav1 protein resistant to caspase cleavage (D150A/
D161A) was generated by PCR-based site-directed mutagenesis. 5 to 20 mg
of DNA were introduced in T cells with a nucleofector device (AMAXA) accord-
ing to the manufacturer’s protocol. Cells were anergized 36 hr after transfec-
tion.
Retroviral Infection of Primary Th1 Cells
GADS, GADS1-223, flag-GADS226-322, Vav1, Vav11-174, and Vav1172-845 cDNAs
were subcloned in the RV-IRES-GFP vector (Macian et al., 2002). Phoenix eco-
tropic packaging cells were transfected with a calcium/phosphate method
with the different retroviral vectors. 48 hr after transfection, retroviral superna-
tants were collected, supplemented with polybrene (8 mg/ml), and used to in-
fect T cells 24 hr after stimulation. Infected cells were sorted for GFP expres-
sion.
RNA Interference
A murine caspase 3-specific shRNA (50-GTAAAGACCATACATGGGA-30) was
introduced into the pSUPER (Oligoengine). 20 mg of DNA (1:4 ratio pMaxGFP
and pC3RNAi) were transfected into 5 3 106 T cells. GFP-positive cells were
sorted 36 hr after transfection and analyzed.
Subcellular Fractionation
Cells were resuspended in ice-cold fractionation buffer (10 mM Tris-HCl [pH
7.5], 5 mM MgCl2, 1 mM EDTA, and 1 mM DTT with protease inhibitors) and
disrupted by sonication. Nuclei were pelleted by centrifugation (700 3 g, 10
min, 4C) and supernatants centrifuged at 100,0003 g for 1 hr at 4C to obtain
the membrane (P100) and the cytosolic (S100) fractions. Alternatively, cells
were resuspended in ice-cold 0.25 M sucrose and disrupted by sonication.
Nuclei were pelleted and supernatants centrifuged at 1450 3 g for 10 min at
4C to obtain the membrane fraction (P1). Centrifugation at 17,000 3 g, 10
min, at 4C was performed to obtain the organelles fraction (mitochondria,
lysosomes, endosomes, and peroxisomes) (P2). A final centrifugation at
100,000 3 g (1 hr at 4C) was performed to separate endoplasmic reticulum
and Golgi (P3).
Statistical Analysis
Differences in the inhibition of IL-2 production in anergic T cells were analyzed
with a Student’s t test (paired, two-tails).
SUPPLEMENTAL DATA
Supplemental Data include four figures and can be foundwith this article online
at http://www.immunity.com/cgi/content/full/29/2/193/DC1/.
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